Upfront autologous hematopoietic stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma: A real-world multicenter study
For patients with newly diagnosed high-risk DLBCL, consolidated ASCT therapy can increase the DFS rate of those with CR status following the R-CHOP regimen, and the safety is controllable.
Authors
- Zhiqiang Sun (ORCID: https://orcid.org/0000-0003-1977-5263)
- Xiaochen Xiang (ORCID: https://orcid.org/0000-0001-5285-5148)
- Qiang Wang (ORCID: https://orcid.org/0000-0002-0466-5013)
- Zhi Guo (ORCID: https://orcid.org/0009-0005-8029-2457)
- Jingye Meng
- Yueqiao Wang (ORCID: https://orcid.org/0000-0002-7117-1646)
- Bo Lü (ORCID: https://orcid.org/0000-0002-2798-2775)
- Yongqian Li (ORCID: https://orcid.org/0009-0005-7342-7456)
- Liang Wang (ORCID: https://orcid.org/0000-0003-3045-4903)
- Guowei Li (ORCID: https://orcid.org/0000-0002-1184-1791)
- Xiaojun Xu
- Min Zhou (ORCID: https://orcid.org/0000-0003-2477-4513)
- Jing Xie (ORCID: https://orcid.org/0000-0001-6825-0178)
- Xiaomin Xian
- Jun Wang (ORCID: https://orcid.org/0009-0008-8475-2934)
Institutions
- Beijing Tongren Hospital (CN)
- Sun Yat-sen University (CN)
- Capital Medical University (CN)
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Southern University of Science and Technology (CN)
- The Seventh Affiliated Hospital of Sun Yat-sen University (CN)
- Huizhou Central People's Hospital (CN)
- Shantou Central Hospital (CN)
- University of Hong Kong - Shenzhen Hospital (CN)
- Southern Medical University Shenzhen Hospital (CN)
- Shenzhen University Health Science Center (CN)
- Shenzhen Third People’s Hospital (CN)
- Wuhan University of Science and Technology (CN)
- Guangzhou Medical University (CN)
Publication Details
- Journal
- Journal of Cancer Research and Therapeutics
- Published
- 2025-05-01
- DOI
- https://doi.org/10.4103/jcrt.jcrt_2102_24
- Citations
- 1
- Primary Topic
- Lymphoma Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.47